Pazdur On Accelerated Approval: FDA Needs To Explain Why It Does Not Always Seek Withdrawal When Trials Fail

 
• By Sue Sutter
  
knee
A nuanced approach, rather than a knee-jerk reaction, is needed in deciding whether to pull an accelerated approval drug with a failed confirmatory trial. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards